Tyson Foods Inc., a leading global meat processor, has announced it will remove the "No Antibiotics Ever" label from select chicken products, reintroducing antibiotics not significant to human treatment. This policy shift has raised eyebrows, given the growing concern about antibiotic resistance fueled by food production practices.
Tyson Foods ditched the drug for infections eight years ago, and since then, the “no antibiotics ever” has been emblazoned on its chicken products’ label packaging. Then again, only some of the chicken items are set to lose the mentioned phrase on the label.
According to CNN Business, the Springdale, Arkansas-based food processing company will start using antibiotics in its chicken production and said that this is the type that is not important to the treatment of humans. In any case, the use of antibiotics in food production or processing has been heavily scrutinized in recent years because some bacteria have become resistant to medicines and treatment due to repeated exposure to antibiotics.
“At Tyson Foods, we base our decisions on sound science and an evolving understanding of the best practices impacting our customers, consumers, and the animals in our care,” the spokesperson of Tyson Foods said in a statement.
The company said that some of its chicken would start deleting the “no antibiotics important to human medicine” on the label by the end of this year. Tyson Foods ascertained it would only apply antibiotics that are up to the standard and recognized by the USDA and the World Health Organization (WHO).
It was in 2015 when the company announced its decision to eliminate the antibiotics in its chicken wings, breast, and chicken nuggets. At the time, the company said it was working to get rid of the drug as it was worried about the increase in antibiotic-resistant bacterial infections in humans. It added that it would like to play its part in helping reduce the human consumption of antibiotics.
Meanwhile, The Wall Street Journal was the first to report on Tyson Foods’ decision to resume its use of non-medically important antibiotics in some of its chicken production. “Based on current science, Tyson brand products are transitioning to No Antibiotics Important to Human Medicine (NAIHM), which is expected to be complete by the end of the calendar year,” the company’s representative stated.


China Industrial Profit Growth Slows as Weak Demand Offsets AI Gains
Nissan Targets US Hybrid Growth With Rogue e-Power Launch
US Appeals Court Upholds Anthropic AI Supply Chain Ban
China Cuts Tariffs on U.S. Farm Goods but Excludes Soybeans
ECB May Stop Rate Hikes After December, Capital Economics Says
Dubai’s connectivity remains strong in an uncertain world
Novo Nordisk Strikes €1.17 Billion Nanexa Drug Delivery Deal
Morgan Stanley Raises TD Synnex Price Target to $359 on Strong AI Demand
OpenAI Investigates Rogue AI Agents After Data Leaks and Security Incidents
US Comfortable With Canada Trade Standoff as Import Bans Loom
TSMC Accelerates 2nm Expansion as AI Chip Demand Surges
US Stocks Face Jobs, Inflation Test as Fed Rate Hike Bets Rise
Oil Prices Rise as Iran Holds Firm on Strait of Hormuz Deal
OpenAI Agents Access U.S. Government Websites During Testing
Meta Found Liable in New Mexico Facebook Data Privacy Case
Oil Prices Fall on U.S.-Iran Hormuz Deal Hopes
Erste Group Plans Tender Offer to Boost Poland Bank Stake 



